Silva José Thyálisson da Costa, Alencar Gabriel Gonçalves, Araújo Nara Juliana Santos, Nascimento Lariza Leisla Leandro, Menezes Saulo Almeida, Antunes Dhenes Ferreira, Costa Adrielle Rodrigues, Felício Murilo Felipe, Leandro Cicero Dos Santos, de Morais Luis Pereira, Santos Marcos Aurélio Figueirêdo Dos, de Sousa Severino Denicio Gonçalves, Macedo Julimery Gonçalves Ferreira, Junior João Pereira da Silva, Araujo Ana Carolina Ferreira, de Sá Maísa Freire Cartaxo Pires, Andrade-Pinheiro Jacqueline Cosmo, Coutinho Henrique Douglas Melo, Almeida-Bezerra José Weverton
Department of Biological Sciences, Regional University of Cariri-URCA, Crato, Brazil.
Federal University of Cariri-UFCA, Crato, Brazil.
Chem Biodivers. 2025 Jun 25:e00924. doi: 10.1002/cbdv.202500924.
Antimicrobial resistance is an increasing threat to public health, with alarming estimates of mortality rates. In this context, the clinical properties of Varronia curassavica Jacq. are highlighted due to its biological and pharmacological activities. This study aims to analyze the phytochemical composition of the essential oil from V. curassavica (EOVC) and its antibiofilm activity against Gram-positive and Gram-negative strains. The essential oil was extracted from the leaves using hydrodistillation and analyzed by gas chromatography-mass spectrometry (GC-MS), phytochemical analysis of EOVC identified 97.36% of the total composition, predominantly composed of monoterpenes (α-pinene at 44.46%) and sesquiterpenes (β-caryophyllene at 21.82%). Antibiofilm tests were performed on five bacterial strains (both Gram-positive and Gram-negative) to evaluate the ability to inhibit and eradicate biofilms, with statistical analysis of the results. Antibiofilm formation tests demonstrated that EOVC exhibited efficacy against Staphylococcus aureus and Staphylococcus epidermidis, with minimum inhibitory concentrations (MIC) of 1.024 and 10.240 µg/mL, respectively, values comparable to those observed for the reference antibiotic. In addition, at high concentrations (10 × MIC), EOVC inhibited biofilm development by Streptococcus mutans and Enterococcus faecalis, achieving performance similar to that of gentamicin. In biofilm eradication assays, EOVC showed effective activity against E. faecalis, S. epidermidis, and S. aureus at concentrations of 10.240 µg/mL, equivalent to gentamicin. However, resistance was found in strains of Pseudomonas aeruginosa and S. mutans, with P. aeruginosa showing the highest level of resistance to EOVC.
抗菌耐药性对公众健康构成的威胁日益增加,死亡率估计令人担忧。在此背景下,由于其生物学和药理活性,库拉索瓦罗尼木(Varronia curassavica Jacq.)的临床特性受到关注。本研究旨在分析库拉索瓦罗尼木精油(EOVC)的植物化学成分及其对革兰氏阳性和革兰氏阴性菌株的抗生物膜活性。采用水蒸馏法从叶片中提取精油,并通过气相色谱 - 质谱联用仪(GC - MS)进行分析,EOVC的植物化学分析确定了其总成分的97.36%,主要由单萜类化合物(α - 蒎烯占44.46%)和倍半萜类化合物(β - 石竹烯占21.82%)组成。对五种细菌菌株(革兰氏阳性和革兰氏阴性)进行了抗生物膜测试,以评估其抑制和根除生物膜的能力,并对结果进行统计分析。抗生物膜形成测试表明,EOVC对金黄色葡萄球菌和表皮葡萄球菌具有疗效,最低抑菌浓度(MIC)分别为1.024和10.240 μg/mL,这些值与参考抗生素观察到的值相当。此外,在高浓度(10×MIC)下,EOVC抑制了变形链球菌和粪肠球菌的生物膜形成,其性能与庆大霉素相似。在生物膜根除试验中,EOVC在浓度为10.240 μg/mL时对粪肠球菌、表皮葡萄球菌和金黄色葡萄球菌显示出有效活性,与庆大霉素相当。然而,在铜绿假单胞菌和变形链球菌菌株中发现了耐药性,其中铜绿假单胞菌对EOVC的耐药性最高。